Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Veracyte (VCYT) Return on Sales (2016 - 2025)

Veracyte (VCYT) has disclosed Return on Sales for 14 consecutive years, with 0.29% as the latest value for Q4 2025.

  • Quarterly Return on Sales rose 25.0% to 0.29% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.13% through Dec 2025, up 7.0% year-over-year, with the annual reading at 0.13% for FY2025, 7.0% up from the prior year.
  • Return on Sales hit 0.29% in Q4 2025 for Veracyte, up from 0.14% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.29% in Q4 2025 to a low of 1.14% in Q1 2021.
  • Historically, Return on Sales has averaged 0.12% across 5 years, with a median of 0.1% in 2023.
  • Biggest five-year swings in Return on Sales: tumbled -76bps in 2021 and later surged 93bps in 2022.
  • Year by year, Return on Sales stood at 0.16% in 2021, then soared by 69bps to 0.05% in 2022, then plummeted by -506bps to 0.29% in 2023, then surged by 115bps to 0.04% in 2024, then skyrocketed by 576bps to 0.29% in 2025.
  • Business Quant data shows Return on Sales for VCYT at 0.29% in Q4 2025, 0.14% in Q3 2025, and 0.01% in Q2 2025.